眼睑皮脂腺癌研究进展

Progress of Research on Sebaceous Gland Carcinoma of the Eyelid

眼睑皮脂腺癌是起源于眼睑皮脂腺的高度致命性肿瘤,在我国其发病率位居眼睑恶性肿瘤的第二位,仅次于基底细胞癌。眼睑皮脂腺癌的临床表现多样,极易误诊和漏诊,具有恶性程度高、高复发率和高转移率等特点。目前我国临床上对眼睑皮脂腺癌的认识还不够,缺乏标准的诊断标准和规范的治疗手段,早期诊断和早期治疗是提高生存率、降低复发率和转移率的关键。因此,本文对眼睑皮脂腺癌的流行病学特征、诊断标准、临床分期及治疗新进展等方面进行综述,以期为实际临床工作提供参考。

Sebaceous gland carcinoma(SGC)of the eyelid is a highly lethal tumor which usually originated from eyelid sebaceous gland.In China,eyelid SGC ranked second in eyelid malignant tumors,second only to basal cell carcinoma.The clinical features of eyelid SGC are diverse,making it easily misdiagnosed and missed in diagnosis.Eyelid SGC is highly malignant,with high recurrence and metastasis rates.Eyelid SGC has not been clinically clear enough,and there is a lack of standard criteria for the diagnosis and treatment of eyelid SGC.Early diagnosis and treatment are critical for improving the survival rate and reducing the recurrence and metastasis rates.The study reviews the diagnosis,clinical stage and treatment of eyelid SGC to aid the clinical practices.